Last reviewed · How we verify
Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking
Approved treatments
- Chantix · Pfizer Inc.
Varenicline binds α4β2 neuronal nicotinic acetylcholine receptors as partial agonist, blocking nicotine binding and dopamine reward.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking treatment landscape brief
- Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking treatment updates RSS
Frequently asked questions about Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking
What drugs treat Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking?
Tracked treatments include Chantix.
What is the treatment for Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking?
Standard treatment for Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking includes Chantix. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking patent cliff · Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking CI report
- Treatment: Chantix · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing